Up­dat­ed: Mer­ck gives few de­tails on 2024 re­struc­tur­ing plan for man­u­fac­tur­ing net­work

Mer­ck re­cent­ly ap­proved a re­struc­tur­ing plan for this year, the glob­al phar­ma an­nounced dur­ing its full-year and fourth-quar­ter earn­ings re­port on Thurs­day.

Al­though Mer­ck didn’t in­clude de­tails, the re­struc­tur­ing pro­gram is meant to “con­tin­ue the op­ti­miza­tion of the com­pa­ny’s Hu­man Health glob­al man­u­fac­tur­ing net­work as the fu­ture pipeline shifts to new modal­i­ties, and al­so to op­ti­mize the An­i­mal Health glob­al man­u­fac­tur­ing net­work to im­prove sup­ply re­li­a­bil­i­ty and in­crease ef­fi­cien­cy,” the com­pa­ny said. The re­struc­tur­ing re­sult­ed in charges in its GAAP re­sults of $190 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.